BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target
Accessibility Tools

BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target

BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target

Gallbladder cancer (GBC) is highly aggressive and has poor prognosis, with most patients only diagnosed at an advanced stage.

Source: Nature

Read more

430 Pennsylvania Ave.
Suite 350
Glen Ellyn, IL 60137

Tel:

Get Directions

3011 Butterfield Road
Suite 240
Oak Brook, IL 60523

Tel:

Get Directions

5101 S Willow Springs Road
Suite: Bariatric Clinic
La Grange, IL 60525

Tel:

Get Directions

Click here to book the appointment using setmore